Cited by 88Barrier Structure and Function StudiesHIV Research and TreatmentNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 261 of the 261 references it cites were found in a registry or an index.

Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS

Open access

Buckner, Clarisa M., Luers, Aimée J., Calderon, Tina M., Eugenin, Eliseo A., Berman, Joan W.·2006·Journal of Neuroimmune Pharmacology

DOI 10.1007/s11481-006-9017-3PMC PMC4359614

Open this paper in CoChat — free account

Abstract

HIV infection of the central nervous system (CNS) can result in neurologic dysfunction with devastating consequences in a significant number of individuals with AIDS. Two main CNS complications in individuals with HIV are encephalitis and dementia, which are characterized by leukocyte infiltration into the CNS, microglia activation, aberrant chemokine expression, blood-brain barrier (BBB) disruption, and eventual damage and/or loss of neurons. One of the major mediators of NeuroAIDS is the transmigration of HIV-infected leukocytes across the BBB into the CNS. This review summarizes new key findings that support a critical role of the BBB in regulating leukocyte transmigration. In addition, we discuss studies on communication among cells of the immune system, BBB, and the CNS parenchyma, and suggest how these interactions contribute to the pathogenesis of NeuroAIDS. We also describe some of the animal models that have been used to study and characterize important mechanisms that have been proposed to be involved in HIV-induced CNS dysfunction. Finally, we review the pharmacologic interventions that address neuroinflammation, and the effect of substance abuse on HIV-1 related neuroimmunity.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1007/s11481-006-9017-3

Cites

261 of 261 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Identification of RANTES, MIP-1α, and MIP-1β as the Major HIV-Suppressive Factors Produced by CD8 + T Cells
Cocchi, F., DeVico, A. L., Demo, A. G., Arya, S. K., Gallo, R. C., & Lusso, P. (1995) · Science · doi:10.1126/science.270.5243.1811 · Cited by 2,867
Pericyte Loss and Microaneurysm Formation in PDGF-B-Deficient Mice
Lindahl, P., Johansson, B. R., Levéen, P., & Betsholtz, C. (1997) · Science · doi:10.1126/science.277.5323.242 · Cited by 2,226
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Rácz, P., Tenner‐Racz, K., Dalesandro, M. R., Scallon, B. J., et al. (1999) · Science · doi:10.1126/science.283.5403.857 · Cited by 2,167
Memantine in Moderate-to-Severe Alzheimer's Disease
Reisberg, B., Doody, R., Stöffler, A., Schmitt, F., Ferris, S., & Möbius, H. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa013128 · Cited by 2,043
Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ-opioid-receptor gene
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
Junctional Adhesion Molecule, a Novel Member of the Immunoglobulin Superfamily That Distributes at Intercellular Junctions and Modulates Monocyte Transmigration
Martín-Padura, I., Lostaglio, S., Schneemann, M., Williams, L., Romano, M., Fruscella, P., Panzeri, C., Stoppacciaro, A., Ruco, L., Villa, A., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.142.1.117 · Cited by 1,387
THE CELL BIOLOGY OF THE BLOOD-BRAIN BARRIER
Rubin, L. L., & Staddon, J. M. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.11 · Cited by 1,017
Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia
Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958
Drug resistance in brain diseases and the role of drug efflux transporters
Löscher, W., & Potschka, H. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1728 · Cited by 920
Mortality, CD4 Cell Count Decline, and Depressive Symptoms Among HIV-Seropositive Women
Ickovics, J. R., Hamburger, M. E., Vlahov, D., Schoenbaum, E. E., Schuman, P. C., BOLAND, R. J., & Moore, J. (2001) · JAMA · doi:10.1001/jama.285.11.1466 · Cited by 885

Show all 260 references

Research works printed but not linked: 1

Benagiano V, Virgintino D, Maiorano E, Rizzi A, Palombo S, Roncali L, Ambrosi G (1996) VIP-like immunoreactivity within neurons and perivascular neuronal processes of the human cerebral cortex. Eur J Histochem 40:53–56

Sorted by citations

Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
The impact of microglial activation on blood-brain barrier in brain diseases
da Fonseca, A. C. C., Matias, D., Garcia, C., Amaral, R., Geraldo, L. H., Freitas, C., & Lima, F. R. S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00362 · Cited by 572
Tunneling nanotubes (TNT) are induced by HIV-infection of macrophages: A potential mechanism for intercellular HIV trafficking
Eugenin, E. A., Gaskill, P. J., & Berman, J. W. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2008.08.005 · Cited by 304
Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus
Daep, C. A., Muñoz‐Jordán, J. L., & Eugenin, E. A. (2014) · Journal of NeuroVirology · doi:10.1007/s13365-014-0285-z · Cited by 206
Neurodegeneration and Ageing in the HAART Era
Brew, B. J., Crowe, S. M., LANDAY, A. L., Cysique, L. A., & Guillemin, G. J. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9143-1 · Cited by 204
MicroRNA Regulation of IFN-β Protein Expression: Rapid and Sensitive Modulation of the Innate Immune Response
Witwer, K. W., Sisk, J. M., Gama, L., & Clements, J. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902712 · Cited by 186
Brain angiogenesis in developmental and pathological processes: regulation, molecular and cellular communication at the neurovascular interface
Lee, H. S., Han, J., Bai, H., & Kim, K. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07174.x · Cited by 175
The Gut Immune Barrier and the Blood-Brain Barrier: Are They So Different?
Daneman, R., & Rescigno, M. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.012 · Cited by 167
Opioid and nociceptin receptors regulate cytokine and cytokine receptor expression
Finley, M. J., Happel, C., Kaminsky, D. E., & Rogers, T. J. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2007.09.008 · Cited by 139
Human Immunodeficiency Virus (HIV) Infection of Human Macrophages Is Increased by Dopamine
Gaskill, P. J., Calderon, T. M., Luers, A. J., Eugenin, E. A., Javitch, J. A., & Berman, J. W. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.081067 · Cited by 131
Gap Junctions Mediate Human Immunodeficiency Virus-Bystander Killing in Astrocytes
Eugenín, E. A., & Berman, J. W. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4154-07.2007 · Cited by 130
The Comorbidity of HIV-Associated Neurocognitive Disorders and Alzheimer’s Disease: A Foreseeable Medical Challenge in Post-HAART Era
Xu, J., & Ikezu, T. (2008) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-008-9136-0 · Cited by 120
Drug Induced Increases in CNS Dopamine Alter Monocyte, Macrophage and T Cell Functions: Implications for HAND
Gaskill, P. J., Calderon, T. M., Coley, J. S., & Berman, J. W. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9443-y · Cited by 77
Emerging role of P2X7 receptors in CNS health and disease
Tewari, M., & Seth, P. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.10.001 · Cited by 80
HIV and viral protein effects on the blood brain barrier
McRae, M. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1143543 · Cited by 74
Risk Factors and Pathogenesis of HIV-Associated Neurocognitive Disorder: The Role of Host Genetics
Olivier, I. S., Cacabelos, R., & Naidoo, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113594 · Cited by 74
Abrogated Inflammatory Response Promotes Neurogenesis in a Murine Model of Japanese Encephalitis
Das, S., Dutta, K., Kumawat, K. L., Ghoshal, A., Adhya, D., & Basu, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017225 · Cited by 65
Alcohol consumption effect on antiretroviral therapy and HIV-1 pathogenesis: role of cytochrome P450 isozymes
Kumar, S., Jin, M., Ande, A., Sinha, N., Silverstein, P. S., & Kumar, A. (2012) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2012.714366 · Cited by 70
Novel mechanisms of central nervous system damage in HIV infection
Eugenin, E. (2010) · HIV/AIDS - Research and Palliative Care · doi:10.2147/hiv.s9186 · Cited by 70
The Impact of HIV and Malaria Coinfection: What Is Known and Suggested Venues for Further Study
Hochman, S. E., & Kim, K. (2009) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2009/617954 · Cited by 65
The impact of substance abuse on HIV-mediated neuropathogenesis in the current ART era
Chilunda, V., Calderon, T. M., Martínez-Aguado, P., & Berman, J. W. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146426 · Cited by 66
Locus Coeruleus and neurovascular unit: From its role in physiology to its potential role in Alzheimer’s disease pathogenesis
Giorgi, F. S., Galgani, A., Puglisi‐Allegra, S., Limanaqi, F., Busceti, C. L., & Fornai, F. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24718 · Cited by 69
The Effects of Opioids on HIV Neuropathogenesis
Murphy, A., Barbaro, J. M., Martínez-Aguado, P., Chilunda, V., Jaureguiberry-Bravo, M., & Berman, J. W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02445 · Cited by 58
The Influence of Virus Infection on Microglia and Accelerated Brain Aging
Filgueira, L., Larionov, A. A., & Lannes, N. (2021) · Cells · doi:10.3390/cells10071836 · Cited by 59
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells
Kanmogne, G. D., Kanmogne, G. D., Singh, S., Roy, U. B., Liu, X., McMillan, Gorantla, Balkundi, Zhou, Y., Alnouti, et al. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29454 · Cited by 56
The role of Locus Coeruleus in neuroinflammation occurring in Alzheimer’s disease
Giorgi, F. S., Saccaro, L. F., Galgani, A., Busceti, C. L., Biagioni, F., Frati, A., & Fornai, F. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.08.007 · Cited by 53
Neural-Immune Interactions in Brain Function and Alcohol Related Disorders
Cui, C., Noronha, A., & Grandison, L. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0 · Cited by 54
CD 4+ T cells in the pathobiology of neurodegenerative disorders
Huang, X., Reynolds, A. D., Mosley, R. L., & Gendelman, H. E. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.04.006 · Cited by 51
Molecular Mechanism of HIV-1 Tat Interacting with Human Dopamine Transporter
Yuan, Y., Huang, X., Midde, N. M., Quizon, P. M., Sun, W., Zhu, J., & Zhan, C. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00001 · Cited by 47
Involvement of CX3CL1/CX3CR1 in depression and cognitive impairment induced by chronic unpredictable stress and relevant underlying mechanism
Liu, Y., Zhang, T., Meng, D., Sun, L., Yang, G., He, Y., & Zhang, C. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112371 · Cited by 51
Nanoparticle Based Galectin-1 Gene Silencing, Implications in Methamphetamine Regulation of HIV-1 Infection in Monocyte Derived Macrophages
Reynolds, J. L., Law, W., Mahajan, S. D., Aalinkeel, R., Nair, B. B., Sykes, D. E., Yong, K., Hui, R., Prasad, P. N., & Schwartz, S. A. (2012) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-012-9379-7 · Cited by 48
Simvastatin Protects against Amyloid β and HIV-1 Tat-Induced Promoter Activities of Inflammatory Genes in Brain Endothelial Cells
Andras, I. E., Rha, G. B., Huang, W., Eum, S. Y., Couraud, P., Romero, I. A., Hennig, B., & Toborek, M. J. (2008) · Molecular Pharmacology · doi:10.1124/mol.107.042028 · Cited by 44
Human brain endothelial cells are responsive to adenosine receptor activation
Mills, J. H., Alabanza, L. M., Weksler, B. B., Couraud, P., Romero, I. A., & Bynoe, M. S. (2011) · Purinergic Signalling · doi:10.1007/s11302-011-9222-2 · Cited by 43
HIV-Tat regulates macrophage gene expression in the context of neuroAIDS
Carvallo, L., Lopez, L., Fajardo, J. E., Jaureguiberry-Bravo, M., Fiser, A., & Berman, J. W. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179882 · Cited by 39
Imaging serotonergic transmission with [11C]DASB-PET in depressed and non-depressed patients infected with HIV
Hammoud, D. A., Endres, C. J., Hammond, E. R., Uzuner, Ö., Brown, A. M., Nath, A., Kaplin, A. I., & Pomper, M. G. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.10.037 · Cited by 40
Microglial response to viral challenges: Every silver lining comes with a cloud
Kaushik, D. K. (2011) · Frontiers in bioscience · doi:10.2741/3847 · Cited by 36
Factor Analysis of Proton MR Spectroscopic Imaging Data in HIV Infection: Metabolite-derived Factors Help Identify Infection and Dementia
Mohamed, M. A., Lentz, M. R., Lee, V., Halpern, E. F., Sacktor, N. C., Selnes, O. A., Barker, P. B., & Pomper, M. G. (2010) · Radiology · doi:10.1148/radiol.09081867 · Cited by 37
HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood–brain barrier integrity
Leibrand, C. R., Paris, J. J., Jones, A. M., Masuda, Q. N., Halquist, M. S., Kim, W., Knapp, P. E., Kashuba, A. D. M., Hauser, K. F., & McRae, M. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00757-8 · Cited by 36
Cannabinoid Inhibition of Macrophage Migration to the Trans-Activating (Tat) Protein of HIV-1 Is Linked to the CB2 Cannabinoid Receptor
Raborn, E. S., & Cabral, G. A. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163055 · Cited by 36
Connexin 43: An Interface Connecting Neuroinflammation to Depression
Jiang, H., Zhang, Y., Wang, Z., & Chen, N. (2023) · Molecules · doi:10.3390/molecules28041820 · Cited by 36
The role of human dopamine transporter in NeuroAIDS
Zhu, J., Ananthan, S., & Zhan, C. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.007 · Cited by 30
The Impact of HIV Coinfection on Cerebral Malaria Pathogenesis
Hochman, S. E., & Kim, K. (2012) · Journal of Neuroparasitology · doi:10.4303/jnp/235547 · Cited by 33
Brain ingress of regulatory T cells in a murine model of HIV-1 encephalitis
Gong, N., Liu, J., Reynolds, A. D., Gorantla, S., Mosley, R. L., & Gendelman, H. E. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.08.014 · Cited by 29
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins
Raborn, E. S., Jamerson, M., Marciano‐Cabral, F., & Cabral, G. A. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.04.008 · Cited by 27
NeuroAIDS, Drug Abuse, and Inflammation: Building Collaborative Research Activities
Berman, J. W., Carson, M. J., Chang, L., Cox, B. M., Fox, H. S., González, R. G., Hanson, G. R., Hauser, K. F., Ho, W., Hong, J., et al. (2006) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-006-9048-9 · Cited by 25
[3H]Dopamine Uptake through the Dopamine and Norepinephrine Transporters is Decreased in the Prefrontal Cortex of Transgenic Mice Expressing HIV-1 Transactivator of Transcription Protein
Strauss, M. J., O’Donovan, B., Ma, Y., Xiao, Z., Lin, S., Bardo, M. T., Ortinski, P. I., McLaughlin, J. P., & Zhu, J. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.266023 · Cited by 25
Microglia as a Game Changer in Epilepsy Comorbid Depression
Wen, W., Zhou, J., Zhan, C. A., & Wang, J. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03810-0 · Cited by 28
Buprenorphine reverses neurocognitive impairment in EcoHIV infected mice: A potential therapy for HIV-NCI
Murphy, A., Kelschenbach, J., He, H., Chao, W., Kim, B., Volsky, D. J., & Berman, J. W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1004985 · Cited by 22
Inhibition of telomerase activity alters tight junction protein expression and induces transendothelial migration of HIV-1-infected cells
Huang, W., Rha, G. B., Chen, L., Seelbach, M. J., Zhang, B., Andras, I. E., Bruemmer, D., Hennig, B., & Toborek, M. J. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01126.2009 · Cited by 23
Craniula: A cranial window technique for prolonged imaging of brain surface vasculature with simultaneous adjacent intracerebral injection
Zuluaga‐Ramirez, V., Rom, S., & Persidsky, Y. (2015) · Fluids and Barriers of the CNS · doi:10.1186/s12987-015-0021-y · Cited by 21
A new model for post-integration latency in macroglial cells to study HIV-1 reservoirs of the brain
Schneider, M., Tigges, B., Meggendorfer, M., Helfer, M., Ziegenhain, C., & Brack‐Werner, R. (2015) · AIDS · doi:10.1097/qad.0000000000000691 · Cited by 20
HIV-1 transgenic rats display an increase in [3H]dopamine uptake in the prefrontal cortex and striatum
Zhu, J., Yuan, Y., Midde, N. M., Gomez, A. M., Sun, W., Quizon, P. M., & Zhan, C. (2015) · Journal of NeuroVirology · doi:10.1007/s13365-015-0391-6 · Cited by 20
Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter
Sun, W., Quizon, P. M., Yuan, Y., Zhang, W., Ananthan, S., Zhan, C., & Zhu, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-03771-0 · Cited by 19
Inhibition of HIV-1 tat-induced transactivation and apoptosis by the divalent metal chelators, fusaric acid and picolinic acid—Implications for HIV-1 dementia
Ramautar, A., Mabandla, M. V., Blackburn, J. M., & Daniels, W. M. U. (2012) · Neuroscience Research · doi:10.1016/j.neures.2012.05.014 · Cited by 16
Exploring the relationship of macrophage colony-stimulating factor levels on neuroaxonal metabolism and cognition during chronic human immunodeficiency virus infection
Lentz, M. R., Degaonkar, M. N., Mohamed, M. A., Kim, H., Conant, K. E., Halpern, E. F., Sacktor, N. C., Barker, P. B., & Pomper, M. G. (2010) · Journal of NeuroVirology · doi:10.3109/13550284.2010.513029 · Cited by 16
Combination of HIV-1 and Diabetes Enhances Blood Brain Barrier Injury via Effects on Brain Endothelium and Pericytes
Rom, S., Gajghate, S., Winfield, M., Reichenbach, N. L., & Persidsky, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134663 · Cited by 15
Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice
Rademeyer, K. M., Nass, S. R., Jones, A. M., Ohene‐Nyako, M., Hauser, K. F., & McRae, M. (2024) · Journal of NeuroVirology · doi:10.1007/s13365-023-01186-4 · Cited by 12
Methamphetamine and HIV-1 gp120 Effects on Lipopolysaccharide Stimulated Matrix Metalloproteinase-9 Production by Human Monocyte-Derived Macrophages
Reynolds, J. L., Mahajan, S. D., Aalinkeel, R., Nair, B. B., Sykes, D. E., & Schwartz, S. A. (2011) · Immunological Investigations · doi:10.3109/08820139.2011.559499 · Cited by 12
Protease Resistant Protein Cellular Isoform (PrPc) as a Biomarker: Clues into the Pathogenesis of HAND
Megra, B., Eugenin, E., Roberts, T. K., Morgello, S., & Berman, J. W. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9458-4 · Cited by 12
Cellular & molecular basis of HIV-associated neuropathogenesis.
Sharma, D., & Bhattacharya, J. (2009) · PubMed · Cited by 12
HIV-1 and drug abuse comorbidity: Lessons learned from the animal models of NeuroHIV
Sil, S., Thangaraj, A., Chivero, E. T., Niu, F., Kannan, M., Liao, K., Silverstein, P. S., Periyasamy, P., & Buch, S. J. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135863 · Cited by 11
Long-Term Low-Dose Delta-9-Tetrahydrocannbinol (THC) Administration to Simian Immunodeficiency Virus (SIV) Infected Rhesus Macaques Stimulates the Release of Bioactive Blood Extracellular Vesicles (EVs) that Induce Divergent Structural Adaptations and Signaling Cues
Lyu, Y., Kopcho, S., Mohan, M., & Okeoma, C. M. (2020) · Cells · doi:10.3390/cells9102243 · Cited by 9
Inflammation and Connexin 43 profiles in the prefrontal cortex are relevant to stress susceptibility and resilience in mice
Jiang, H., Zhang, M., Wang, H., Zhang, N.-N., Li, X.-M., Yang, X., Chen, A., Xu, Y., Zhang, Z., Chu, S., et al. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173757 · Cited by 8
Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA
Krishnan, G., & Chatterjee, N. (2015) · Scientific Reports · doi:10.1038/srep09887 · Cited by 8
CRISPR/CAS as a Powerful Tool for Human Immunodeficiency Virus Cure: A Review
Komninakis, S. V., Domingues, W., Sanabani, S. S., Folgosi, V. Â., Barbosa, I. N., & Casseb, J. (2024) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2022.0148 · Cited by 6
Binding Mode of Human Norepinephrine Transporter Interacting with HIV-1 Tat
Adeniran, C. A., Yuan, Y., Davis, S. E., Lin, C., Xu, J., Zhu, J., & Zhan, C. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00792 · Cited by 6
Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function
Strauss, M. J., Porter, K. D., Quizon, P. M., Davis, S. E., Lin, S., Yuan, Y., Martínez-Muñiz, G. A., Sun, W., Zhan, C., & Zhu, J. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275182 · Cited by 6
Amyloid beta accumulation in HIV-1 infected brain: the role of altered cholesterol homeostasis.
Chen, X., Liang, H., & Geiger, J. D. (2014) · PubMed · Cited by 6
Aripiprazole Improves Depressive Symptoms and Immunological Response to Antiretroviral Therapy in an HIV-Infected Subject with Resistant Depression
Cecchelli, C., Grassi, G., & Pallanti, S. (2010) · Case Reports in Medicine · doi:10.1155/2010/836214 · Cited by 5
Back-burning to cure HIV: Temporary depletion of all CD4+ cells and elimination of the extracellular reservoir with HIV Immunotoxin Therapy
Zanin, M. K. B., & Duvall, M. R. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2008.08.033 · Cited by 5
Role of Cytochrome P450 Systems in Substance of Abuse Mediated HIV-1 Pathogenesis and NeuroAIDS
Kumar, S. (2012) · Journal of Drug Metabolism & Toxicology · doi:10.4172/2157-7609.1000e102 · Cited by 3
Basic Science of Central Nervous System Infections
Tessier, J. M., & Scheld, W. M. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5316-3.00040-x · Cited by 3
Mutational effects of the asparagine198 and glutamate223 residues on the human norepinephrine transporter on basal and HIV-1 Tat protein-induced inhibition of dopamine transport
Porter, K. D., Adeniran, C. A., Jiménez-Torres, A. C., Pless, K. L., Cirincione, A. B., Davenport, H., Chen, C., Zhan, C., & Zhu, J. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178131 · Cited by 2
HIV-Associated Neurocognitive Disorder
El-Rashedy, A. A. E. (2018) · Advances in healthcare information systems and administration book series · doi:10.4018/978-1-5225-3203-3.ch008 · Cited by 2
Erratum: Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA
Krishnan, G., & Chatterjee, N. (2015) · Scientific Reports · doi:10.1038/srep12206 · Cited by 2
Antigen expression and host-parasite interactions of Plasmodium falciparum infections in Malawian paediatric patients
Tembo, D. L. (2014) · University of Liverpool · doi:10.17638/00011453 · Cited by 1
Nose-to-brain delivery of antiretroviral drugs against NeuroAIDS
Moravkar, K. K., Shah, D. S., Jha, D. K., Amin, P. D., & Surana, S. J. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822522-6.00019-9 · Cited by 1
Neuroimmune Cross Talk and HIV-Associated Neurocognitive Disorders
McMillan, J., & Gendelman, H. E. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_7
Amyloid Beta Accumulation in HIV-1 Infected Brain: The Role of Altered Cholesterol
Chen, X., Lü, H., & Jd, G. (2014)
Analytical Methods for the Study of Opioid Peptides
Al‐Hossaini, A. M. (2017) · KU ScholarWorks (The University of Kansas)
HIV
Morgello, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-33189-8_2
Molecular mechanisms of dopaminergic transmission in NeuroHIV
Zhu, J., Davis, S. E., Zhan, C., & McLaughlin, J. P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99744-7.00018-3
Extracellular vesicles in alcohol and tobacco-induced NeuroAIDS
Kumar, S., Godse, S., Kumar, A., Zhou, L., Mirzahosseini, G., & Patel, K. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-99744-7.00024-9
Genetics and epigenetics of NeuroAIDS
Pant, A., Yadav, S., Arora, R., & Maurya, P. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818851-4.00011-3
Neurotransmission of Immune Cells
Consentino, M., Valdebenito, S., & Eugenín, E. A. (2024) · Springer eBooks · doi:10.1007/978-3-031-68237-7_14
Viral Infections of the CNS: Is It All About Breaching Barriers?
Schmidt, S., & Rudolph, H. (2025) · Current human cell research and applications · doi:10.1007/978-981-97-9495-9_9
Age, gender aspects of nervous system damage in hiv infection and modern treatment options
Yusupov, F. A., Токтосунович, Ы. И., & Yuldashev, A. A. (2025) · Clinical Medicine (Russian Journal) · doi:10.30629/0023-2149-2025-103-4-263-271
Impact of HIV on Neuronal Health in the Brains of People with HIV
Angelovich, T. A., Kivinen, J. J., Byrnes, S. J., Gorry, P. R., & Churchill, M. J. (2026) · Viruses · doi:10.3390/v18090999

Authors: Buckner, C. M., Luers, A. J., Calderon, T. M., Eugenin, E. A., & Berman, J. W.
Affiliations: Albert Einstein College of Medicine (US)
Corresponding author: Berman, Joan W.
ORCID: Buckner, Clarisa M.
Calderon, Tina M.
Berman, Joan W.
Venue: Journal of Neuroimmune Pharmacology
Publisher: Springer Science and Business Media LLC
Published: 2006-04-13
Volume: 1
Issue: 2
Pages: 160-181
ISSN: 1557-1890 (ISSN-L)
1557-1904
DOI: 10.1007/s11481-006-9017-3
PMC: PMC4359614
OpenAlex: W2018506622
Cited by: 88
References: 260
Citations by year: 2026: 1 · 2025: 3 · 2024: 7 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 5 · 2018: 2 · 2017: 4 · 2016: 2 · 2015: 7 · 2014: 6 · 2013: 2 · 2012: 8
FWCI: 3.51
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Journal of Neuroimmune Pharmacology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (5r01mh052974-10)
Center for AIDS Research, University of Washington
National Institute of Mental Health (K01MH076679, MH0702297, R01MH075679, MH 52974)
National Institute of Allergy and Infectious Diseases (P30AI051519, AI 051519)
National Institute of Neurological Disorders and Stroke (T32NS007098, NS-11920, P50NS011920, NS 07098)
Topics: Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: neuroimmunity, blood-brain barrier, HIV infection, neuroAIDS, leukocyte transmigration, HIV-associated encephalitis, HIV-associated dementia, microglial activation, chemokines, neuroinflammation, substance abuse, animal models of HIV, pharmacological interventions
MeSH terms: Acquired Immunodeficiency Syndrome, Animals, Blood-Brain Barrier, Brain, Chemotaxis, Leukocyte, Humans, Neuroimmunomodulation, HIV-1, AIDS Dementia Complex, Substance-Related Disorders

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Neuroimmunity and the blood-brain barrier: molecular regulation of leukocyte transmigration and viral entry into the nervous system with a focus on neuroAIDS

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks